Vir Biotechnology (VIR) Return on Capital Employed Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,400.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | 299.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299.00 |
| Dec 31, 2025 | -801.00 |
| Sep 30, 2025 | -1,170.00 |
| Jun 30, 2025 | -1,844.00 |
| Mar 31, 2025 | -1,794.00 |
| Dec 31, 2024 | -630.00 |
| Sep 30, 2024 | -637.00 |
| Jun 30, 2024 | -2,043.00 |
| Mar 31, 2024 | -2,082.00 |
| Dec 31, 2023 | -7,510.00 |
| Sep 30, 2023 | -10,136.00 |
| Jun 30, 2023 | -7,153.00 |
| Mar 31, 2023 | -10,713.00 |
| Dec 31, 2022 | 332.00 |
| Sep 30, 2022 | 9,502.00 |
| Jun 30, 2022 | 8,834.00 |
| Mar 31, 2022 | 15,032.00 |
| Dec 31, 2021 | 6,960.00 |
| Sep 30, 2021 | 571.00 |
| Jun 30, 2021 | 998.00 |
| Mar 31, 2021 | -760.00 |
| Dec 31, 2020 | 791.00 |